Interferons, uses and compositions related thereto

Details for Australian Patent Application No. 2002228886 (hide)

Owner Pestka Biomedical Laboratories, Inc.

Inventors Pestka, Sidney

Agent Shelston IP

Pub. Number AU-B-2002228886

PCT Pub. Number WO02/36627

Priority 60/245,754 03.11.00 US; 60/246,234 03.11.00 US

Filing date 5 November 2001

Wipo publication date 15 May 2002

Acceptance publication date 30 August 2007

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 33/00 (2006.01) Antiparasitic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

C07K 14/555 (2006.01) Peptides having more than 20 amino acids

C07K 14/56 (2006.01) Peptides having more than 20 amino acids

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

23 September 2004 Amendment Made

  The nature of the amendment is: Amend the name of the applicant/patentee from PBL Biomedical Laboratories to Pestka Biomedical Laboratories, Inc.

30 August 2007 Application Accepted

  Published as AU-B-2002228886

3 January 2008 Standard Patent Sealed

31 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002228887-Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy

2002228885-Simultaneous quantification of nucleic acids in diseased cells